An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
Pricing in Europe has moved from an operational task to a core strategic function; RGM reframed growth from “selling more” to “earning more profitably” Specialist consulta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results